Skip to main content

Newsroom

Newsroom

Filter

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin

As featured in 21st.BIO has earned a self-affirmed GRAS status for its animal-free beta-lactoglobulin ingredient, which customers can now launch in the United States market. 21st.BIO is helping customers bring…
September 4, 2024

21st.BIO in Food Ingredients First

21st.BIO highlighted in Food Ingredients First's special report on precision fermentation   In this article, our co-founder and CEO Thomas Schmidt discusses the challenges and essential steps for precision fermentation…
August 9, 2024

21st.BIO in Børsen

How can we accelerate the path to sustainable food and nutrition production?   Our co-founder and CEO Thomas Schmidt discusses Denmark’s role in pioneering sustainable nutrition production in an opinion piece for Børsen. Denmark is…
July 17, 2024

New publication in Annual Reviews of Food Science and Technology

We are thrilled to announce the publication of our latest scientific paper, "The Next Food Revolution Is Here: Recombinant Microbial Production of Milk and Egg Proteins by Precision Fermentation" in…
July 1, 2024

21st.BIO at Folkemødet

Biosolutions are moving center stage.   Our CEO Thomas Schmidt was attending Folkemødet, Denmark's "People's Meeting" in Bornholm this week with our colleague Barbara Taudorf, Director of Commercial Development and…
June 14, 2024

21st.BIO’s pilot plant inauguration

Last Friday, we were lucky to welcome over a hundred guests to the grand opening of our pilot plant facility. We started with an exclusive roundtable, gathering twenty executives and…
May 12, 2024

21st.BIO at SynBioBeta

Our co-founder and CSO Per Falholt is in San Jose this week for SynBioBeta. On Monday, Per participated in a fantastic fireside chat organized by Boston Consulting Group (BCG) where…
May 8, 2024

21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally

As featured in Combining world-class industrially proven technology with fermentation capacity, 21st.BIO helps customers get to scale faster, in a risk-mitigated and cost-effective way. Margrethe Vestager, Executive Vice President of…
May 6, 2024

EU Commission takes action to boost biotechnology and biomanufacturing

Today, the EU Commission unveiled a set of initiatives outlined in its "Communication on Biotechnology and Biomanufacturing," aimed at boosting biotech & biomanufacturing within the EU.   One of the…
March 20, 2024

21st.BIO at the Bioprocessing Summit EUrope

Meet us at the Bioprocessing Summit Europe this week in Barcelona. Our colleagues José Arnau, Director of Strain Development & Regulatory Affairs, and Carl Overgaard, Fermentation Scientist, are onsite and ready…
March 19, 2024

Danish Ministers and industry organizations visit 21st.BIO

Last week was another great event for us at 21st.BIO: we had the pleasure of opening our doors to a delegation of ministers and interest organizations leading the important green three-way…
March 12, 2024

New article in Weekendadvisen

We're happy to see our work highlighted in Weekendadvisen this week. Our co-founder and CEO, Thomas Schmidt, discussed some key points with reporter Andreas Rygaard: Denmark has significantly influenced the…
March 8, 2024

21st.BIO promotes biosolutions’ potential at the Danish Parliament

Yesterday, our CEO Thomas Schmidt was invited to speak at the Danish Parliament's Business Committee on the potential of biosolutions.   Tons of strong data points were presented during the…
March 1, 2024

New industry report by the Boston Consulting Group and Synonym

"How to get precision fermentation biomanufacturing to cost-efficiency?" That's precisely the question Boston Consulting Group's latest report, 'Breaking the cost barrier in Biomanufacturing', intends to answer. The report was written in…
February 28, 2024

21st.BIO at the European High-Level Summit on Biosolutions

With world-leading biotechnology companies and ambitious emissions reduction targets, the EU holds a unique opportunity to lead the way in the sustainable production of foods, materials, or even fuels. Now…
February 23, 2024

21st.BIO opens a more sustainable avenue for industrial scale dairy protein production

Global bioproduction leader 21st.BIO today announced it is granting access to its precision fermentation technology platform to ingredient manufacturers enabling the production of dairy proteins at competitive cost. This follows…
January 31, 2024

AMSilk and 21st.BIO announce partnership to accelerate the production of advanced materials made from spider silk-based proteins

New protein production strain delivers unprecedented yield with greater efficiency and lower costs.
January 17, 2024

21st.BIO at the Biofabricate Summit 2023

The summit showcased incredibly innovative companies, exploring the boundless possibilities of biotechnology for the future of materials and cosmetics. We know that the 21st.BIO technology and expertise will be pivotal…
January 12, 2024

New article in Nature Biotechnology

For the past years, the world-class science teams of 21st.BIO and AMSilk have been collaborating very closely to develop and scale the production of spider silk proteins, which is predicted to become a disruptive force…
December 15, 2023

21st.BIO at the Biosolutions high-level Summit 2023

We presented samples of our milk protein (beta-lactoglobulin), and shared our vision around the need for building production capacity in Denmark, Europe and beyond.
November 21, 2023

New article in Danske Bank

We're proud to see our work showcased by Danske Bank. We are proud ambassadors of the precision fermentation field, advocating the potential of this technology to advance the green transition.
November 17, 2023

New article in Børsen

We have the technology and competencies in Denmark and in Europe to take the lead globally on precision fermentation. And with that we can make a real impact on both the…
October 26, 2023

Novo Holdings invests 86m EUR in 21st.BIO

Novo Holdings invests 86 million EUR in 21st.BIO, a bioindustrial scale-up company with a technology base from Novozymes.
December 21, 2021